316
Participants
Start Date
June 27, 2017
Primary Completion Date
November 27, 2019
Study Completion Date
December 1, 2031
RO7046015
RO7046015 will be administered at dose of 4500 milligrams (mg) for participants with body-weight greater than or equal to (\>/=) 65 kilograms (kg) or 3500 mg for participants with body-weight less than (\<) 65 kg.
RO7046015
RO7046015 will be administered at dose of 1500 mg to all participants in the indicated arm.
Placebo
RO7046015 placebo will be administered to all participants in the indicated arm.
Medizinische Universität Innsbruck, Innsbruck
Columbia University, New York
Klinik fur Neurologie, Berlin
hopital de la Timone, Marseille
University of Rochester Medical Center, Rochester
UNIVERSITY of PENNSYLVANIA, Philadelphia
Policlínica Guipuzcoa, Donostia / San Sebastian
Hospital Universitario de la Princesa, Madrid
Fundacion Hospital de Alcorcon, Alcorcón
Clinica Universidad de Navarra, Pamplona/iruña
CIC - Hôpital Purpan, Toulouse
Compass Research East, LLC, Orlando
Groupe Hospitalier Pellegrin, Bordeaux
Aventura Neurologic Associates, Aventura
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
USF Parkinsons Disease and Movement Disorders Center, Tampa
Paracelsus Elena Klinik Kassel, Kassel
Philipps Universität Marburg, Marburg
Uab Medicine, Birmingham
Vanderbilt University Medical Center, Nashville
Hôpital Michallon - Centre d'Investigation Clinique, Grenoble
Heinrich-Heine Universitätsklinik Düsseldorf, Düsseldorf
Hospital Universitario Virgen Macarena, Seville
CHU de Nantes - Hopital Laennec, Saint-Herblain
Henry Ford Health System, West Bloomfield
Quest Research Institute, Farmington Hills
Corewell Health Neurology and Epilepsy - Beltline, Grand Rapids
Northwestern University, Evanston
Hopital Gabriel Montpied, Clermont-Ferrand
University of Kansas Medical Center, Kansas City
Universitaettsklinikum Tübingen, Tübingen
The Movement Disorder Clinic of Oklahoma, Tulsa
Hopital Pitie-Salpetriere APHP, Paris
CHU Rouen Charles Nicolle, Rouen
Baylor College, Houston
Central Texas Neurology Consultants, Round Rock
CenExel Rocky Mountain Clinical Research, LLC, Englewood
DZNE Clinical Trial Unit, München
Barrow Neurology Clinics, Phoenix
CHU Poitiers, Poitiers
Universitätsklinikum Ulm, Ulm
USC Keck Medical Center of USC, Los Angeles
Neurology Center of North Orange County, Fullerton
Hopital Henri Mondor, Créteil
University of California at San Francisco, San Francisco
Oregon Health & Science Uni, Portland
Associated Neurologists of Southern CT PC, Fairfield
Molecular Neurolmaging, New Haven
Beth Israel Deaconess Medical Center, Boston
University of Vermont Medical Center, Burlington
CHU de Nice Hopital Pasteur, Nice
Klinik und Poliklinik für Neurologie Universitätsklinikum, Leipzig
Hospital General de Catalunya, Sant Cugat del Vallès
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
Prothena Biosciences Limited
INDUSTRY
Hoffmann-La Roche
INDUSTRY